Introduction of KCNA7
KCNA7 encoded by KCNA7 gene is a member of potassium channel, voltage-gated, shaker-related subfamily which regulates the transportation of potassium ions across the membrane in accordance with their electrochemical gradient. KCNA7 protein has 456 amino acid residues and 6 transmembrane segments (S1-S6) forming a central core domain, cytoplasmic N- and C-termini. The S4 with shaker-type repeat is probably the voltage-sensor. The N-terminus may be very essential for determining the rate of inactivation of the channel. KCNA7 is primarily expressed in skeletal muscle, heart, and kidney.
|Basic Information of KCNA7|
|Protein Name||Potassium voltage-gated channel subfamily A member 7|
|Organism||Homo sapiens (Human)|
Function of KCNA7 Membrane Protein
KCNA7 functions as a voltage-gated potassium channel subunit involved in the regulation of potassium ion permeability of excitable membranes in accordance with their electrochemical gradient. It has been revealed that KCNA7 is responsible for the cardiac transient outward potassium current which is the main contributing current for repolarization phase 1 of the cardiac action potential. KCNA7 has been reported to be associated with the development of inherited cardiac disorders. Furthermore, KCNA7 is widely found in skeletal muscle where it involves in the hypoxia-induced membrane depolarization responses. And the T418M polymorphism in KCNA7 is associated with the aerobic endurance. Additionally, KCNA7 is also expressed in pancreatic beta-cells where it regulates insulin secretion. During glucose-stimulated insulin secretion (GSIS), KCNA7 has been revealed to mediate the KCNA7 membrane-repolarizing current of beta cells. And blocking KCNA7 could increase GSIS. Hence, KCNA7 antagonists may be regarded as a potential therapeutic strategy for Type 2 diabetes.
Fig.1 Domain structure and structural conservation between potassium channel subfamilies. (Sandoz, 2013)
Application of KCNA7 Membrane Protein in Literature
The study indicates that Kv1.7 is responsible for the main membrane-repolarizing current of beta cells during glucose-stimulated insulin secretion (GSIS). Moreover, blocking Kv1.7 may be a potential therapeutic strategy for Type 2 diabetes.
The study shows that the increased activity of voltage-gated K(+) (K(v)) channels may be associated with the proapoptotic and/or antiproliferative effects of BMP-2 on pulmonary artery smooth muscle cells.
The study identifies Kv1.7 channels as molecular entities of potential importance in cellular redox-stress conditions such as hypoxia via mRNA expression profile and redox modulation of mKv1.7 kinetics.
The study shows the possible role of Kv1.4, Kv1.7, TASK2 and TASK3 channels in human spermatozoa. But Kv1.5 and mink may serve as the most possible candidates for human sperm regulatory volume decrease.
The study proves that KCNA7 may be not a candidate gene causing progressive familial heart block I (PFHBI). Further studies need to investigate the role of KCNA7 in the heart.
KCNA7 Preparation Options
To obtain the soluble and functional target protein, the versatile Magic™ membrane protein production platform in Creative Biolabs enables many flexible options, from which you can always find a better match for your particular project. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-KCNA7 antibody development services.
As a forward-looking research institute as well as a leading custom service provider in the field of membrane protein, Creative Biolabs has won good reputation among our worldwide customers for successfully accomplishing numerous challenging projects including generation of many functional membrane proteins. Please feel free to contact us for more information.
All listed customized services & products are for research use only, not intended for pharmaceutical, diagnostic, therapeutic or any in vivo human use.